Arturo Molina MD Insider Trading Activity
Arturo Molina MD has been net-selling over the last 12 months with 0 purchases and 6 sales across 1 company.
PTGX is the most-traded position with 6 trades. The largest single transaction was a sale of PTGX for $1.6M on Mar 26, 2026.
Performance Scorecard
Forward stock performance after each transaction by Arturo Molina MD. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -0.7% | 38% | 8 |
| 90 days | — | -13.2% | 25% | 8 |
| 120 days | — | -20.9% | 0% | 8 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersPTGX · Protagonist Therapeutics, Inc
🔒 Subscribe to see trade entries
Pro members see exactly when Arturo Molina MD bought and sold PTGX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 26, 2026 | PTGX | Sell | 15,000 | $104.79 | $1.6M | −15.1% | Chief Medical Officer | |
Jan 27, 2026 | PTGX | Sell | 5,000 | $82.00 | $410K | −5.6% | Chief Medical Officer | |
Jan 26, 2026 | PTGX | Sell | 5,000 | $82.28 | $411K | −5.6% | Chief Medical Officer | |
Jan 23, 2026 | PTGX | Sell | 13,151 | $82.42 | $1.1M | −13.5% | Chief Medical Officer | |
Jan 20, 2026 | PTGX | Sell | 9,514 | $82.48 | $785K | −8.9% | Chief Medical Officer | |
Nov 17, 2025 | PTGX | Sell | 2,712 | $84.77 | $230K | −3.2% | Chief Medical Officer | |
Jun 10, 2025 | PTGX | Sell | 10,000 | $57.03 | $570K | −10.7% | Chief Medical Officer | |
Jun 9, 2025 | PTGX | Sell | 10,000 | $55.51 | $555K | −10.7% | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | 8 | $5.6M |
Other insiders at Protagonist Therapeutics, Inc
4 other tracked filers at PTGX.